About Ono

History

Apothecary started by Ichibei Fushimiya, which developed into ONO PHARMACEUTICAL CO., LTD. (illustration from a guidebook of Osaka, 1867)

Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

1717  The first Ichibei Ono set up the apothecary “Fushimiya Ichibei” in Doshomachi, Osaka.
1934 Reorganized to an unlimited partnership, and changed the name to “Ono Ichibei Shoten”.
1947 ONO PHARMACEUTICAL CO., LTD. was established.
1962 Listed on the Osaka Securities Exchange.
1963 Listed on the Tokyo Stock Exchange.
1968 Completion of the Central Research Institute (Current the Minase Research Institute).
Made a world-first success of total synthesis of prostaglandin (PG) as a public corporation.
1975 Completion of the Fujiyama Plant.
1978 Completion of the new head office building (Current the head branch)
1982 The London office was opened in the United Kingdom.
1985 Completion of the Fukui Research Institute for safety assessment.
1987 Completion of the new building for the Minase Research Institute (renamed from the Central Research Institute).
1989 Completion of the main building for the Minase Research Institute.
1990 The Seattle office was opened in the U.S.A.
1994 The Seoul office was opened in South Korea (Later Seoul Branch).
1995 Completion of the new building for Tokyo Branch (Current the Tokyo Office).
1998 ONO PHARMA UK LTD. and ONO PHARMA USA, INC. were established. (The London office and the Seattle office developed into ONO PHARMA UK LTD. and ONO PHARMA USA, INC., respectively.)
2003 The Tsukuba Research Institute was opened.
Completion of the new Head Office building.
2013 ONO PHARMA KOREA CO., LTD. was established in South Korea (The Seoul office developed into ONO PHARMA KOREA., LTD.)
2014 ONO PHARMA TAIWAN CO., LTD. was established in Taiwan
2016 Completion of the new Research Building (The Third Building) in the Minase Research Institute

Picture of the shop front (mid-19th century)

The old head office building in Doshomachi, the pharmaceutical hub of Osaka

Minase Research Institute

Fujiyama Plant

Fukui Research Institute

Tsukuba Research Institute

Corporate headquarters building